About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
- Clear all filters
- December
- Canadian Air Transport Security Authority
- Canadian Human Rights Commission
- Export Development Canada
- Federal Public Service Health Care Plan Administration Authority
- Health Canada
- Office of the Commissioner of Lobbying of Canada
- Office of the Information Commissioner of Canada
- Shared Services Canada
Report Type
Organization
Disposition
Year
Month
Found 478 record(s)
Req # A-2022-001552
Regarding an agreement in principle for a shared plan that will invest $4.81 billion in federal funding over 10 years in Nova Scotia. All documents related and/or regarding the following queries: Identify the plan of action regarding improved access…Organization: Health Canada
December 2023
Req # A-2023-000230
All documents submitted by BioNTech Manufacturing Company GmbH or Pfizer as part of the regulatory review that resulted in the Regulatory Decision Summary dated September 16, 2021 for the Comirnaty Vaccine. The full regulatory review decision from…Organization: Health Canada
December 2023
Req # A-2023-000553
Health Canada is currently reviewing an Abbreviated New Drug Submission (ANDS) seeking approval of a product containing the medicinal ingredient estradiol. Advise if the proposed dosage form of the Estradiol ANDS is a tablet with an oral route of…Organization: Health Canada
December 2023
Req # A-2023-000590
All notes made by the Health Canada employees who reviewed the Pfizer-BioNTech Comirnaty COVID-19 vaccine, in relation to the review, that were made during the reviewal process of the drug. Date Range: August 1, 2021 to December 31, 2021.Organization: Health Canada
December 2023
Req # A-2023-000592
All notes made by the Health Canada employees who reviewed the Pfizer-BioNTech Comirnaty COVID-19 vaccine, in relation to the review, that were made during the reviewal process of the drug. Date Range: January 1, 2021 to July 31, 2021.Organization: Health Canada
December 2023
Req # A-2023-000593
All notes made by the Health Canada employees who reviewed the Moderna Spikevax COVID-19 vaccines, in relation to the review, that were made during the reviewal process of the drug. Date Range: January 1, 2021 to July 31, 2021.Organization: Health Canada
December 2023
Req # A-2023-000600
All notes made by the Health Canada employees who reviewed the Moderna Spikevax COVID-19 vaccines, in relation to the review, that were made during the reviewal process of the drug. Date Range: August 1, 2021 to December 31, 2021.Organization: Health Canada
December 2023
Req # A-2023-000604
All notes made by the Health Canada employees who reviewed the AstraZeneca Vaxzevria COVID-19 vaccine, in relation to the review, that were made during the reviewal process of the drug. Date Range: August 1, 2021 to December 31, 2021.Organization: Health Canada
December 2023
Req # A-2023-000721
All communication between Director Generals, Directors, Executive Director, Assistant Deputy Minister of Pest Management Regulatory Agency and Human Resources Classification, Labor Relation and Human Resources, Staffing about the two AS-05 positions…Organization: Health Canada
December 2023
Req # A-2023-000747
Inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the human drugs drug establishment licence Good Manufacturing Practices (GMP) inspection of Bausch Health…Organization: Health Canada
December 2023